- Staat
- VA
- Alter
- 1,5
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 15.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash pruritic
Sleep disorder
Varicella
Symptomtext
Patients mother reported that child developed a rash all on her body including her face the day after her vaccine. It was very itchy and child wont sleep because of how itchy it is. Seen by pediatrician in office and diagnosed as having varicella. Was prescribed : Acyclovir Hydroxyzine Chlorhexidine Gluconate solution Diphenhydramine Child to be seen by pediatrician in one week
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; PROQUAD was inadvertently administered to the following patient after its labeled expiry date.; This spontaneous report was received from a nurse referring to a 6-year-old female patient. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. On 28-APR-2023, the patient was inadvertently vaccinated with expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin [rhA]) (PROQUAD) injection, lot #U029321, expiration date: 19-MAR-2023, administered for prophylaxis (strength, dose, and route of administration were not provided) (Expired product administered). The vaccine had not undergone any temperature excursions. No additional AE reported (No adverse event). This is one of three reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 16.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; Nurse reported that PROQUAD was inadvertently administered to the following patient after its labeled expiry date; This spontaneous report was received from a nurse referring to a 9-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 28-APR-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection (lot#: U029321, expiration date: 19-MAR-2023; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 16.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; Nurse reported that PROQUAD was inadvertently administered to the following patient after its labeled expiry date; This spontaneous report was received from a nurse referring to a 9-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 28-APR-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection (lot#: U029321, expiration date: 19-MAR-2023; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 16.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; Nurse reported that PROQUAD was inadvertently administered to the following patient after its labeled expiry date; This spontaneous report was received from a nurse referring to a 9-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 28-APR-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection (lot#: U029321, expiration date: 19-MAR-2023; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Nurse reported that PROQUAD was inadvertently administered to the following patient after its labeled expiry date. The involved PROQUAD had a labeled expiry of 3/19/2023 and was administered on 4/28/2023.; This spontaneous report was received from a nurse and referred to a 4-year-old male patient. The patient's medical history, concurrent conditions were not reported. Concomitant therapies included sterile diluent. On 28-APR-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, lot #U029321, expiration date: 19-MAR-2023, administered for prophylaxis (strength, dose, and route of administration were not provided) (expired product administered). The vaccine had not undergone any temperature excursions. The reporter was unable to provide the lot number and expiry date for the sterile diluent; however, she stated it was not expired. No additional adverse event was reported (no adverse event). This is one of the several reports from the same reporter.; Sender's Comments: US-009507513-2305USA000867: US-009507513-2305USA000923:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 01.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired vaccine given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 28.04.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired and not discovered until patient left
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 06.03.2023
- Impfdatum
- 24.01.2023
- Beginn
- 24.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient given MMRV, product not licensed for patient age. No adverse reaction noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 02.03.2023
- Beginn
- 02.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Inadvertently gave MMRV which is not for the age group of 17 and older, also in giving the MMRV, this nurse also gave a dose of Varicella to the client. After giving the doses Supervisor notified, as well as Dr. notified. Contact made to current residence of patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- None identified
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Nurse reporting PROQUAD was administered after a temperature excursion. No additional AE. No PQC.; Nurse reporting PROQUAD was administered after a temperature excursion. No additional AE. No PQC.; This spontaneous report was received from a a registered nurse referring to a patient of unknow age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions, or concomitant medications was not provided. On 03-MAY-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) at a dose of 0.5 mL as prophylaxis (route of administration, vaccination scheme frequency, anatomical location were not reported; valid lot number U029321 with expiration date 19-MAR-2023). The administered dose of the vaccine experienced a temperature excursion -12 degrees Celsius (C) for 24 hours. There were no previous temperature excursions before, adverse effects, or product quality complaints (PQC).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 13.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Parents were notified by physician
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 13.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cellulitis
Symptomtext
Patient received MMR-V & PCV-13 on 4/1/22 in the right leg. She has now developed cellulitis of her leg.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 12.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 12.04.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Erythema
Symptomtext
Patient had redness on 4/1/22 that initially went away, but came back on an unknown date. On 4/11 patient's mother calls providers office to report symptoms. 4/12 patient's mother brings her in and Dr. diagnosed patient with Cellulitis. Treated with Cephalexin 250mg TID x 7 days starting on 4/12.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- Covid-19 on 2/19/22
- Vorgeschichte
- no
- Andere Medikamente
- n/a
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 04.04.2022
- Impfdatum
- 22.03.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 10,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient moved from where he had not gotten any vaccines. He came in to get started on the required vaccines he needed for school but was to old for Quadracel. Patient did not have any adverse reaction, was just advised to submit VAERS by Department of Public Health
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- -
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No additional AE or PQC reported.; a patient only received half a dose of PROQUAD due to moving around when the vaccine was injected; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 16-MAR-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #U029321, expiration date: 19-MAR-2023, administered for prophylaxis (strength, side and route of administration were not provided). Administered vaccine was diluted in a 0.5 ml sterile diluent (lot# U002746, expiration date: 25-JUN-2023). The patient received only half a dose of the vaccine due to moving around when the vaccine was being injected (accidental underdose). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 14.03.2022
- Impfdatum
- 05.03.2022
- Beginn
- 05.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
New patient came to clinic to establish care with Aunt. No vaccine records presented when intake was done. Later during the visit-mother arrived with vaccine and records. CMA placed all records on RN desk. (RN was with another patient). When RN saw vaccine records she entered all vaccines in chart. Per vaccine records patient was to receive an MMR. The RN did not see the records that reflected that the child had received 2 MMR's. Pediatrician informed immediately upon realization of error. Child returned to clinic 3/08/22. Aunt stated child did not have any adverse effects and was feeling well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -